Test Overview
Clinical Utility
This assay is intended for use as a tumour marker. It is standardized against the 1st IRP WHO Reference Standard 72/225.
Method
Electrochemiluminescent immunoassay (ECLIA)
Analytical Platform
Roche Elecsys
Result Included
α-Fetoprotein
Aliases/Synonyms
AFP
Specimen
Specimen Type
SerumVolume
Sample Volume
1 mL
Patient Preparation
Samples should not be taken from patients receiving therapy with high biotin doses (i.e. >5 mg/d) until at least 8 hours following the last biotin administration.
Stability
| Refrigerated | Frozen |
|---|---|
| 7 days | 3 Months |
Performance & Interpretation
Turnaround Time
5 days
Results
Name
Units
Reference Range
Conversion
-
α-Fetoproteinµg/L&ly;2m: 17200 - 44350
<4m: 88 - 412
<6m: 16 - 127
<9m: 11 - 67
<12m: 5 - 27
<13m: 4 - 17
≥13m: 0 - 10ng/mL x 1.00
Comment
Results obtained with Roche Elecsys assay. Results from other manufacturers cannot be used interchangeably.
Referral Location
Canada
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| AFPTUM | AFP | 2922 | ug/L |
Test Version
Last Updated
2025-06-11